cardiac output is the volume of blood ejected from each of the ventricles of the heart per minute, and is therefore the product of stroke volume and heart rate. The unit of cardiac output is L.min Stroke volume is the volume of blood ejected by each contraction of the ventricle and is determined by the preload, afterload and contractility. The stroke volume is usually 60-80ml for an average sized adult.
preload describes the tension developed in the ventricular wall at end-diastole (i.e. at maximal filling just prior to contraction). This tension is difficult to measure and end-diastolic pressure is taken as a surrogate (or estimate) measurement. It is mainly determined by venous return and gives an indication of the filling pressure of the ventricle. contractility refers to the amount of work the heart can generate, at given levels of preload and afterload, and is estimated by the maximum rate at which the ventricle can generate a change of pressure over time. Inotropy is used to explain an increase in the work done by the heart that is independent of heart rate, preload and afterload.
afterload is the tension that needs to be generated in the ventricular wall in order to eject blood into the arterial system during systole. This is largely determined by the resistance of the arterial systemthe systemic vascular resistance (SVR). It is calculated by: SVR = Mean arterial pressure (mmHg) -Central venous pressure (mmHg) x 80
Cardiac output (L.min Mean arterial pressure (Map) is the average arterial blood pressure throughout the cardiac cycle. As 2/3 of the cardiac cycle is spent in diastole, and 1/3 in systole, MAP may be calculated using the formula: MAP = Diastolic BP + 1/3(Systolic BP -Diastolic BP) ejection fraction is the fraction of total blood in a ventricle that is ejected per beat. It applies to both the left and right ventricles. It gives an index of contractility. Normal value is in the region of 55-65%.
clinical indicatoRS oF caRdiac output
The interpretation of data from invasive haemodynamic monitoring is made in light of the clinical examination. No single clinical sign can be used to make an accurate assessment of cardiac output. Heart rate, blood pressure, pulse strength at various sites, patient colour, respiratory rate and core to peripheral temperature gradient all give an indication to a patient's haemodynamic status. Note that although blood pressure is often used as an indicator of cardiac output, it is frequently unhelpful. Blood pressure may be maintained by intense peripheral vasoconstriction in the face of a perilously low cardiac output.
A patient's ability to compensate for a haemodynamic insult is highly variable, depending on age, premorbid status and other comorbidities. An example is the rise in the diastolic pressure in early hypovolaemic shock, associated with peripheral vasoconstriction that is usually only seen in young, fit individuals. In addition, clinical parameters such urine output, capillary refill time and cognitive function give a guide to end organ perfusion. Change in heart rate, blood pressure and central venous pressure in response to a straight leg raise is useful to predict a patient's response to a fluid bolus.
Measurement of lactate and base deficit in arterial blood and, in particular, the trend of these variables over time gives non-specific information about a patient's organ perfusion. Lactate is produced by anaerobic metabolism, and is an indicator of tissue hypoperfusion. It is measured on most modern blood gas machines. It can be used to monitor therapy, as it will fall as oxygen delivery improves, and as liver perfusion (which enables lactate metabolism) increases.
The oxygen saturation in central venous blood (ScvO 2 ) also gives a global indication of haemodynamic status, is useful in directing fluid therapy 3 and is a reliable surrogate of mixed venous oxygen saturation (see under pulmonary artery flotation catheters, below).
improves with stretching of the ventricular muscle fibres, to a certain optimal point beyond which further stretching impairs performance (see Figure 1) . To apply this strategy we would like to know the left ventricular end-diastolic volume (LVEDV) and monitor changes in the LVEDV as we give fluid boluses. The best surrogate estimate of LVEDV we have is to use a pulmonary artery catheter (PAC) to measure pulmonary artery occlusion ('wedge') pressure, which gives us an estimate of left atrial pressure, which is in turn and estimate of LVEDP, which is a surrogate of LVEDV (and makes assumptions about normal compliance of the left ventricle). This is not a reliable measure of filling, particularly given the effects of ventilation, applied PEEP and the anatomical location of the catheter tip in different lobar pulmonary artery branches. Thermodilution using the PAC does provide an accurate measurement of cardiac output, which can be measured continuously given the correct equipment, however use is diminishing in many parts of the world, due to concerns over safety and lack of robust evidence to support their use.
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Learning point -blood pressure is a poor indicator of cardiac output.
oveRvieW oF tHe Role oF caRdiac output MonitoRinG Mortality in sepsis increases by 15-20% for each 'organ failure' that a patient develops. 1 Organ failure results when delivery of oxygen is inadequate for the organ's requirements. Since the 1980s, research has suggested that optimisation of oxygen delivery (a product of cardiac output and blood oxygen content) in high risk surgical patients prevents organ failure and improves mortality. 2 This has been investigated early in critical illness, and prior to, during and after surgery. 2 Although no single study provides categorical evidence, the weight of evidence suggests that therapies directed at enhancement of oxygen delivery (goal-directed therapy) should be our aim. There is also increasing evidence that, while hypovolaemic septic patients need fluid to optimise their cardiovascular delivery of oxygen, excessive liberal fluid therapy may be harmful.
The major factor limiting this field of clinical practice has been development of a monitoring device that will reliably and accurately guide our use of fluid therapy -to recognise where fluid is needed and give enough, but not too much. Measurement of 'filling' is difficult. We aim to apply Starling's Law, where cardiac performance Currently, the main focus of research and development is towards less invasive monitors with inherently lower risks of use. Broadly these are monitors that use Doppler analysis of the aortic blood velocity (viewed from the oesophagus) or monitors that analyse the shape of the arterial waveform ('pulse contour analysis').
Some of the cardiac output monitors that rely on arterial waveform analysis, use thermo-or indicator dilution to obtain an accurate estimate of cardiac output, which can then be used to calibrate continuous analysis of the waveform, transduced from a modified arterial catheter. In order to make these easier to set up and use, more recent models calibrate their pulse contour analysis using population data, based on age, weight and height. The disadvantage is that the population data is derived from healthy volunteers, and so is not validated for patients with abnormal vascular resistance, which undoubtedly has a major effect on derived indices such as stroke volume. The oesophageal Doppler also uses population data to estimate aortic diameter.
However, even if we are sceptical about the absolute numbers generated, these monitors can be reliably used to observe trends in stroke volume, and the effect of interventions such as fluid administration. The key feature is to determine whether the patient is fluid responsive; meaning that a bolus of fluid augments their cardiovascular performance (for example their stroke volume), thereby improving oxygen delivery. Fluid responsiveness implies that we have moved the patient up the Starling curve.
A current and future area of development is the use of stroke volume variation (SVV) or pulse pressure variation (PPV) that is measured from the transduced arterial waveform. We have long observed that hypovolaemia causes an exaggerated swing in systolic pressure during the respiratory cycle; SVV and PPV quantify this swing or variation as a single number. Again, it is a change in the number, rather than the absolute value that is useful in assessing the fluid responsivenesss of your patient.
From a pragmatic perspective, these monitors are most useful when observing the effect of a single intervention (such as fluid administration) in isolation -this is often difficult during the changing stimuli of surgery, or when the physiological response to sepsis is changing rapidly. Measurements are most plausible when interventions and pre-and post-stroke volume, SVV or PPV measurements are performed during a 'lull' in other stimulating activity.
doppleR ultRaSound and ecHocaRdioGRapHy ultrasound
Ultrasound is any high-frequency sound wave. Ultrasound is used medically to create a 2 dimensional image by using a probe to transmit high-frequency sound waves (1-5MHz) into the body, and to detect the waves as they are reflected off the boundaries between tissues interfaces. By using a mathematical model involving the speed of sound and the intensity and timing of each echo's reflection, the distance from the probe to the tissue boundaries is calculated, and used to create a two-dimensional image.
doppler ultrasound
When sound waves are reflected from a moving object, their frequency is altered. This is the Doppler effect. By using an ultrasound probe to visualise directional blood flow, the phase shift (i.e. the change in frequency before and after reflection off moving red blood cells) can be determined. This, together with the cross-sectional area of the blood vessel being observed (measured or estimated) can be used to determine flow, where:
Flow = area x velocity oesophageal doppler

Theory of technique
A Doppler probe is inserted into the distal oesophagus ( Figure 2 ) and is directed to measure the blood flow in the descending aorta at about 35 to 40cm from the incisors. The monitor calculates cardiac output using descending aorta diameter, which is either obtained from an age-related nomogram or measured directly in newer machines. The ventricular ejection time, corrected for heart rate (the corrected flow time, FTc), gives an indication of preload and the peak flow velocity (PV) estimates the contractility of the ventricle. Newer probes incorporating M-mode Doppler measurement may improve accuracy and reliability.
Practical application
The technique is straight-forward, easily learned and relatively noninvasive. The disposable probes are easy to insert, however some expertise must be gained in recognition of intracardiac and pulmonary artery signals. Continuous measurement is possible, although frequent positional adjustments are needed. Some user variability is inevitable. The cardiac output data is best used as a trend to guide the effectiveness of interventions such as fluid challenges.
Wave form interpretation
A full description of the use of oesophageal Doppler is beyond the scope of this article but guidance can be obtained from the NHS Technology Adoption Centre at http://www.ntac.nhs.uk/searchresent. aspx?search=cardioQ enters the descending aorta. May therefore be inaccurate in a hypovolaemic patient where flow may be redirected to the cerebral circulation.
• Contraindicated in the presence of oesophageal varices.
transthoracic echocardiography
Echocardiography is cardiac ultrasound and can be used to estimate cardiac output by direct visualisation of the contracting heart in real time. Echocardiography is becoming widely accepted as one of the safest and most reliable cardiac output monitors in the critically ill.
A focused echocardiogram can be performed in a matter of minutes and assist in determining the cause of haemodynamic instability. Using transthoracic echocardiography four views are obtained (parasternal long axis, parasternal short axis, apical, and subcostal), and it is possible to make an assessment of ventricular function and size of cardiac chambers with these.
transoesophageal echocardiography
Theory of technique A specialized probe is inserted into the oesophagus, providing real-time, high resolution ultrasound images. Both qualitative and quantitative values for cardiac output are available, using a two dimensional crosssectional area measurement, a Doppler flow measurement at that point and the heart rate.
Practical application
A multiplane transducer is inserted into the oesophagus and stomach, where various standardized views are gained.
Advantages A large amount of haemodynamic information is available beyond just cardiac output. 
Disadvantages
The probes are still expensive and the machinery is large and bulky. Various levels of examination skill are required and these take time and resources to learn. A full study can take over twenty minutes. Some form of local pharyngeal anaesthesia or sedation is required to tolerate the probe. There is a risk of trauma from the probe, although the risks are low in patients with no oesophageal disease. The probes generate a degree of heat and are therefore not suited to continuous measurement. As the technology advances and costs decrease, TOE may find more applications in theatre and the ICU.
dilution MetHodS
These techniques require:
• a marker substance that can completely mix with blood, remain within the circulatory system, and is minimally metabolised.
• a central vein (into which the marker substance is injected) and a peripheral artery (from which the arterial content of the substance can be measured) must be cannulated.
As long as blood flow between the injection and measuring sites is constant, flow (i.e. cardiac output) can be calculated from the area under a concentration versus time graph, using a modified StewartHamilton equation.
Advantages of dilution methods
• Less invasive than PAFC (see below).
Disadvantages of dilution methods
• Can only be used to calculate cardiac output in ventilated patients in sinus rhythm.
• Specific heart-lung interaction is required for the calculation of stroke volume variation (SVV) and pulse pressure variation (PPV)
• Invasive and associated morbidity / mortality.
• User dependent.
• Can underestimate cardiac output in low output states.
lithium dilution Monitoring -lidco® and pulseco® and lidcoplus®
Theory of technique
This technique combines the techniques of lithium dilution (Lidco and Lidcoplus) and pulse contour analysis (PulseCO). A small dose of lithium is injected into a peripheral vein and an ion selective electrode is attached to a peripheral arterial line. The area under the curve of a plot of lithium concentration against time allows calculation of the cardiac output. This information is then used to calibrate the PulseCO which provides 'beat-to-beat' cardiac output measurement, using pulse contour analysis of the arterial waveform.
Practical application
The convenience of this system is that it uses catheters which are likely to be in place or are likely to be needed in a critically ill patient. The system requires some familiarity to set up, but is relatively quick. The total dose of lithium is small and is clinically insignificant. Calibration is recommended every 8 hours, or after any significant change in the patient's clinical condition.
Advantages
A figure for stroke volume variation is produced and provides an indicator of volume responsiveness to fluid therapy.
Disadvantages
The system cannot be used for patients taking lithium and those who have recently received vecuronium or atacurium. The monitor performs poorly in the presence of atrial fibrillation and other tachyarrhythmias. The system is prone to technical difficulties related to damping and resonance within the measurement system (see page 38).
thermodilution pulse contour monitoring -piccoplus® Theory of technique
This technique utilises thermodilution in combination with Pulse Contour Analysis (PulseCO) to measure cardiac output, and correlates well with the PAFC (below). 'Stroke volume variation' (the mean difference between the highest and lowest arterial pressure wave peaks over 30 seconds) gives an indication of the blood volume status of the patient.
The system is calibrated using intermittent cold transpulmonary thermodilution, where cold fluid is injected through a central venous catheter and traverses the pulmonary circulation. A curve of blood thermodilution is measured in a systemic artery and, in addition to cardiac output, other data is derived. The calculated extra-vascular lung water (EVLW) gives an indication of the water content of the lungs and is increased in left ventricular failure, pneumonia and sepsis. The normal range is 3-10ml.kg -1 and values greater than 14ml.kg -1 are associated with an increased mortality. The intra-thoracic blood volume index gives an indication of blood volume status (normal value 850-1000ml.m 2 ).
PiCCOplus replaced the original PiCCO machines in 2002 and has subsequently been replaced by PICCO 2 with improved displays, automated features and the use of room temperature injectate for calibration.
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Practical application
A specialised arterial catheter, inserted into either the brachial artery or femoral artery is required, along with either a thoracic or femoral central line. Some centres use treatment algorithms based on these variables, to guide use of fluid and inotropes in an attempt to maximise intravascular filling, without increasing the EVLW and causing pulmonary oedema. The use of EVLW as an endpoint for resuscitation has not been validated.
Advantages
The arterial line can be simultaneously used for blood pressure monitoring and for blood sampling. The system is relatively easy to set up and calibrate. It can also be used to estimate preload using global-end-diastolic volume and index (GEDI), intra-thoracic blood volume (ITBV) and pulmonary vascular permeability index (PVPI) which gives a ratio of EVLW to pulmonary blood volume. Note that pleural effusions do not affect measurements.
Disadvantages
The arterial catheter is relatively large gauge and expensive, although few complications have been reported. Recalibration is required every 12 hours, or following a major change in the patient's clinical condition. Variations in speed of injection and thermistor positioning may affect results. Results can be affected by arrhythmias, shunting, positive pressure ventilation and tricuspid regurgitation. pulse contour analysis ProAQT (Pulsion), Vigileo (Edwards Lifesciences) and LIDCOrapid (LIDCO) are all similar, minimally invasive cardiac output monitors. They all work by pulse contour analysis using a specialised transducer on any arterial line. Parameters obtained may include: continuous cardiac output, stroke volume, stroke volume variation (SVV) and pulse pressure variation (PPV). In order to obtain SVRi (the systemic vascular resistance index), the patient needs CVP monitoring. To obtain values for PPV and SVV, the patient should be ventilated with a fixed tidal volume and so is less useful when weaning respiratory support in intensive care. dP max gives an indication of contractility.
pulmonary artery flotation catheters (paFc)
The use of PAFCs has been hotly debated in recent years and use in the United Kingdom is currently low. The PAC-Man trial showed no improvement in survival for patients randomised to have a PAFC inserted, compared to those who were not. 3 
Theory of technique
A flexible balloon-tipped, flow-directed catheter is inserted via a wide-bore catheter sited in a central vein. The catheter is 'floated' through the right atrium and ventricle to enter the pulmonary trunk. From this position it can intermittently be 'wedged' in one of the pulmonary arteries.
The catheter allows a number of variables to be measured and others to be derived.
The measured variables are pulmonary artery pressure, pulmonary capillary wedge pressure (PCWP), cardiac output and mixed venous oxygen saturation. Traditionally, cardiac output is measured by thermodilution of 10ml iced water, injected through the proximal lumen of the catheter. Measurement of the fall in blood temperature against time from injection, as the cooled blood passes the distal end of the catheter, allows calculation of the cardiac output of the right (and therefore the left ventricle). Semi-continuous cardiac output measurements are now available which use warming coils in the right ventricular portion of the catheter. A sequence of heating and recording gives an averaged cardiac output after a short delay.
Practical application
The catheter is inserted with reference to certain waveforms seen in the right atrium, right ventricle, pulmonary outflow tract and when wedged in the pulmonary artery. Insertion may take several attempts and is more difficult in patients with a low cardiac output.
Advantages
Measurement of cardiac output is probably the most reliable of the variables measured using a PAFC and is therefore a valuable guide to interventions introduced to increase cardiac output. The numerous assumptions made in interpretation of the PCWP as a measure of preload or ventricular filling make the PCWP a less reliable measurement. Some units use the mixed venous oxygen saturation, measured using a sample taken slowly from the pulmonary artery aperture of the catheter, as a further indicator of a patient's overall tissue perfusion (see below). CeVox (PULSION) is a system which monitors continuous SvO 2 and can calculate oxygen delivery, consumption and oxygen extraction. It uses a fibreoptic probe that can be inserted through any central line.
thoracic bioimpedance
Theory of technique
The technique depends on the change in bioimpedance of the thoracic cavity during systole. Impedance is a measure of the opposition to alternating current. Baseline impedance reflects total thoracic fluid volume. Cardiac output is estimated by measuring changes in electrical resistance through the thorax, since blood volume within the aorta changes during systole and diastole. Magnitude and rate of change reflects LV contractility.
Practical application
A series of ECG type electrodes are placed on the thorax and neck. A small, non-painful current is passed and measurements made.
Advantages
Derived stroke volume is calculated and cardiac output computed. Thoracic fluid content is also measured. This is the least invasive method of cardiac monitoring and was initially conceived for space flight monitoring. 
Method
